Dextenza Versus Topical Steroid Eye Drops for Postoperative Management Following Corneal Crosslinking

Exclusion Criteria

• •History of acute hydrops in treated eye
• •History of pre-existing severe corneal scarring in the treated eye
• •History of pre-existing glaucoma in the treated eye
• •History of or pharmaceutical treatment of glaucoma or ocular hypertension and history or current spikes in intraocular pressure (IOP) in either eye.
• •History of pre-existing ocular inflammation or infection (conjunctivitis, keratitis, uveitis, or retinitis) in treated eye
• •Active infectious systemic disease
• •Obstructed nasolacrimal duct in the study eye(s)
• •Patients with a nasolacrimal duct smaller than 0.4 mm or greater than or equal to 1.0 mm.
• •Patients with stenosis to the location where the insert will be placed should be excluded from the study, as the study team would not engage in surgical procedures to expand or surgically correct that region
• •Hypersensitivity to dexamethasone
• •Patients being treated with immunomodulating agents in the study eye(s)
• •Patients being treated with immunosuppressants and/or oral steroids
• •Patients with severe disease that warrants critical attention, deemed unsafe for the study by the investigator